Join Date
August 2024
Country
Gender
Not Specified
Age
Not Specified
About Kathryn Kwant
Co-founder of Engage Bio
Companies & Work
Engage Bio
Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.
